Monoclonal Antibody Project

We will now be using only combination casirivimab-imdevimab. The process of requesting, receiving, and administering drug will not change, and documents and links below have been updated to reflect the switch to casirivimab-imdevimab combination.

Click here to access the LTCF Monoclonal Antibody Order Survey Link

(Please Note–The survey link above is only for Nursing Home and Assisted Living Residents)

Click here to access the Dialysis Center Monoclonal Antibody Order Survey Link

(Please Note–This survey link is only for HD center patients)


Background Information

Casirivimab-Imdevimab Criteria

REGEN-COV Casirivimab-Imdevimab Antibody Guidebook
(One-stop shop for casirivimab-imdevimab drug information, including administration instructions)

Combination Therapy and Variants of Concern Executive Summary

Original Monoclonal Antibody Project Implementation Plan

Order Form and Fact Sheets

Casirivimab-Imdevimab Prescriber Order Form
(Order form template that can be used to check for eligibility and document ordering the drug in your medical records)

Casirivimab-Imdevimab Medical Director Standing Order Template
(Standing order template that can be used by facility Medical Directors)

Casirivimab-Imdevimab EUA Patient-Caregiver Fact Sheet
(Patient fact sheet that must be printed and given to the patient or caregiver prior to or at the time of infusion)

Casirivimab-Imdevimab Healthcare Provider Fact Sheet
(Fact sheet aimed at providers that contains drug information and answers to other commonly asked questions)

During and After the Infusion

Casirivimab-Imdevimab Administration Instructions

Casirivimab-Imdevimab Emergency Meds
(List of required emergency meds. Note: These can be provided by the pharmacy at time of drug delivery if you do not have them on hand)

Epinephrine Administration for Anaphylaxis
(Helpful information for preparing and administering epinephrine in the case of anaphylaxis)

Reporting Process for Serious Adverse Events

Contact Information

For any questions regarding monoclonal antibodies or the request process, please contact Andrew Watkins at

For facility staff members looking to request infusion training or educational resources, please contact Lisa Brand at

Page last reviewed: June 8, 2021